Dietrich (Rick) John Pauls Insider Profile
4 Followers
Dietrich (Rick) John Pauls, President & Chief Executive Officer at Diamedica Therapeutics, holds 68.59K shares in Diamedica Therapeutics (Ticker: DMAC), holds 880.83K shares in Apteryx (Ticker: TSE:XRAY).
Dietrich (Rick) John Pauls's Trading History
| XRAYApteryx | Feb 15, 2017 | ― | Informative Buy | 50.00K | C$572.54K | |
| DMACDiamedica Therapeutics | ― | President & Chief Executive Officer | ― | $571.36K |
You May Also Like
Dietrich (Rick) John Pauls insider profile FAQ
What is the percentage of profitable transactions made by Dietrich (Rick) John Pauls?
The percentage of profitable transactions made by Dietrich (Rick) John Pauls is 0%.
What is the average return per transaction made by Dietrich (Rick) John Pauls?
The average return per transaction made by Dietrich (Rick) John Pauls is -37.40%.
What stocks does Dietrich (Rick) John Pauls hold?
Dietrich (Rick) John Pauls holds: DMAC, TSE:XRAY stocks.
What was Dietrich (Rick) John Pauls's most profitable transaction?
Dietrich (Rick) John Pauls’s most profitable transaction was an Informative Buy of TSE:XRAY stock on February 15, 2017. The return on the trade was -32.90%.
What is Dietrich (Rick) John Pauls's role in Diamedica Therapeutics?
Dietrich (Rick) John Pauls's role in Diamedica Therapeutics is President & Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
